MedTrace Logo

Prevalence and Genetic Alternation of Autoimmune Polyglandular Syndrome Type II in Taiwan

NCT05578105 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 650

Last updated 2022-10-13

No results posted yet for this study

Summary

Autoimmune polyendocrine syndrome (APS) is an autoimmune disease involving at least two endocrine organ. It is classified into type I and type II diseases. Among them, APS type II is more common. It is diagnosed when two of the three following diseases are diagnosed in the same patient, including type 1 diabetes mellitus, autoimmune thyroid disease, and primary adrenal insufficiency. In this study, we will observe the epidemiology, clinical characteristics, and genetic variants of APS II in Taiwan.

Conditions

  • Autoimmune Polyendocrine Syndrome Type II

Interventions

OTHER

no intervention

No intervention, only observation

Sponsors & Collaborators

  • National Taiwan University Hospital

    lead OTHER

Principal Investigators

  • Shyang-Rong Shih, MD, PhD · National Taiwan University Hospital

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05578105 on ClinicalTrials.gov